Close Menu

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Thursday that its fiscal 2018 first quarter revenues rose 5 percent year over year, thanks largely to a 10 percent increase in revenues from its clinical labs business.

For the three months ended Oct. 31, the molecular diagnostics company reported total revenues of $27.7 million, up from $26.3 million in Q1 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.